86 related articles for article (PubMed ID: 7785244)
1. [Leukemia in delta-GAG-MYC transgenic mice].
Shvemberger IN; Ginkul LB; Ermilov AN
Vopr Onkol; 1994; 40(4-6):198-202. PubMed ID: 7785244
[TBL] [Abstract][Full Text] [Related]
2. [Phenotypic variability in gag-myc transgenic mice].
Ginkul LB; Ermilov AN; Mikulinskaia SM; Shvemberger IN
Vopr Onkol; 1998; 44(5):556-61. PubMed ID: 9884714
[TBL] [Abstract][Full Text] [Related]
3. [Oncogenesis in transgenic mice].
Shvemberger IN; Ermilov AN
Tsitologiia; 1994; 36(2):131-47. PubMed ID: 7809963
[TBL] [Abstract][Full Text] [Related]
4. Neoplastic diseases of the haematopoietic and lymphoid tissues.
Jarrett WF; Mackey LJ
Bull World Health Organ; 1974; 50(1-2):21-34. PubMed ID: 4214049
[TBL] [Abstract][Full Text] [Related]
5. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
6. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
Smith DP; Bath ML; Harris AW; Cory S
Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
8. Fine-needle aspiration cytology of lymphoproliferative lesions involving the major salivary glands.
Chhieng DC; Cangiarella JF; Cohen JM
Am J Clin Pathol; 2000 Apr; 113(4):563-71. PubMed ID: 10761459
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice.
Lange K; Uckert W; Blankenstein T; Nadrowitz R; Bittner C; Renauld JC; van Snick J; Feller AC; Merz H
Oncogene; 2003 Jan; 22(4):517-27. PubMed ID: 12555065
[TBL] [Abstract][Full Text] [Related]
10. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.
Bradley SV; Smith MR; Hyun TS; Lucas PC; Li L; Antonuk D; Joshi I; Jin F; Ross TS
Cancer Res; 2007 Sep; 67(18):8923-31. PubMed ID: 17875735
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Nickel Sulfate Hexahydrate (CAS No. 10101-97-0) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Jul; 454():1-380. PubMed ID: 12587012
[TBL] [Abstract][Full Text] [Related]
13. Plasma cell tumour progression in iMycEmu gene-insertion mice.
Kim JS; Han SS; Park SS; McNeil N; Janz S
J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Jul; 451():1-381. PubMed ID: 12594524
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivo.
Schmitt CA; Lowe SW
Blood Cells Mol Dis; 2001; 27(1):206-16. PubMed ID: 11358381
[TBL] [Abstract][Full Text] [Related]
17. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
18. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
19. Id2 is dispensable for myc-induced lymphomagenesis.
Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
[TBL] [Abstract][Full Text] [Related]
20. Elevated presence of retrotransposons at sites of DNA double strand break repair in mouse models of metabolic oxidative stress and MYC-induced lymphoma.
Rockwood LD; Felix K; Janz S
Mutat Res; 2004 Apr; 548(1-2):117-25. PubMed ID: 15063142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
